Current Edition

Asia Pacific

Korea’s ViroMed acquires DNA-producing facility for clinical trial in U.S.

ViroMed, a Korean developer of biologic drugs, Wednesday announced it has acquired a DNA production facility in San Diego, California, adding a manufacturing function to …

Continue Reading →
350 million

Sanofi to invest €350 million in Canadian vaccine facility

Expansion demonstrates company’s commitment to innovation and leadership in global public health New Toronto facility is one of the largest-ever investments by Sanofi in a …

Continue Reading →